[go: up one dir, main page]

RU93058325A - APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS - Google Patents

APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS

Info

Publication number
RU93058325A
RU93058325A RU93058325/14A RU93058325A RU93058325A RU 93058325 A RU93058325 A RU 93058325A RU 93058325/14 A RU93058325/14 A RU 93058325/14A RU 93058325 A RU93058325 A RU 93058325A RU 93058325 A RU93058325 A RU 93058325A
Authority
RU
Russia
Prior art keywords
hepatitis
treatment
application
derivatives
oxathyolane
Prior art date
Application number
RU93058325/14A
Other languages
Russian (ru)
Other versions
RU2104700C1 (en
Inventor
Аллен Фурман Филипп (младший)
Роберт Пейнтер Джордж (III)
Original Assignee
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919109506A external-priority patent/GB9109506D0/en
Application filed by Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лимитед
Publication of RU93058325A publication Critical patent/RU93058325A/en
Application granted granted Critical
Publication of RU2104700C1 publication Critical patent/RU2104700C1/en

Links

Claims (1)

Предложено применять 1,3-оксатиолановые аналоги нуклеозида и их фармацевтически приемлемые производные для лечения инфекций вируса гепатита В. Предложены также фармацевтические препараты.It is proposed to use 1,3-oxathiolane analogues of nucleoside and their pharmaceutically acceptable derivatives for the treatment of hepatitis B virus infections. Pharmaceutical preparations are also proposed.
RU93058325A 1991-05-02 1992-05-01 Method of hepatitis b treatment RU2104700C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
GB9109506.7 1991-05-02
PCT/GB1992/000803 WO1992019246A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Publications (2)

Publication Number Publication Date
RU93058325A true RU93058325A (en) 1997-01-27
RU2104700C1 RU2104700C1 (en) 1998-02-20

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058325A RU2104700C1 (en) 1991-05-02 1992-05-01 Method of hepatitis b treatment

Country Status (14)

Country Link
EP (1) EP0583274A1 (en)
JP (1) JPH06506929A (en)
AU (1) AU1662092A (en)
CA (1) CA2102120A1 (en)
GB (1) GB9109506D0 (en)
IE (1) IE921363A1 (en)
IL (1) IL101757A0 (en)
MX (1) MX9203214A (en)
MY (1) MY137298A (en)
PT (1) PT100435B (en)
RU (1) RU2104700C1 (en)
UA (1) UA37251C2 (en)
WO (1) WO1992019246A1 (en)
ZA (1) ZA923185B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
DE69912842T2 (en) 1998-12-23 2004-05-13 Shire Biochem Inc., Laval ANTIVIRAL NUCLEOSIDE ANALOG
AR049297A1 (en) * 2004-06-08 2006-07-12 Vertex Pharma A PHARMACEUTICAL COMPOSITION AND SOLID DISPERSIONS OF VX-950 (INHIBITOR OF THE HCV PROTEASE NS3 / 4A) AND OBTAINING PROCESS
RU2331420C2 (en) * 2005-12-08 2008-08-20 Роберт Шалвович Бибилашвили Antiviral agent (versions) and treatment method based on it

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
CA2055433A1 (en) * 1989-05-15 1990-11-16 Jay H. Hoofnagle Method of treatment of hepatitis
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Similar Documents

Publication Publication Date Title
CA2105486A1 (en) Therapeutic nucleosides
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
RU94013464A (en) NUCLEOSIDE ANALOGUES 1,3-OXATIOLANE, METHOD OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING VIRAL INFECTION
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
RU93043875A (en) 1- (2-HYDROXYMETHYL) -1,3-OXATIOLAN-5-IL) -5-fluorocytosine AND METHOD OF TREATMENT
DK602988A (en) NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
ITMI931522A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
WO1998001144A2 (en) Antiviral agents from plant extracts and use for treatment of viral infections
FI20001231A7 (en) 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives and their analogues and their use as antiviral agents
NO875209D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-SUBSTITUTED PYRIMIDINE NUCLEOSIDES.
EA199901031A1 (en) Derivatives of benzimidazole
DK92788A (en) USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
DE3679353D1 (en) ANTIVIRAL CONNECTIONS.
RU93058325A (en) APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS
DE69004451D1 (en) Prophylaxis and treatment of herpes virus infections.
LV10191A (en) Pharmaceuticals for the treatment of infections and diseases caused by hepatitis B virus
MY137298A (en) Therapeutic nucleosides
ATE122562T1 (en) PENCICLOVIR DERIVATIVES FOR THE TREATMENT OF HEPATITIS B INFECTIONS.
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
TH13799A (en) Anti-HBV Pyrimidine Nucleoside
RU93046287A (en) AMINODIOL PROTESIS INHIBITORS
TH10132A (en) Inhibition of human immunodeficiency virus (HIV) by adjuvant interaction of nucleoside derivatives.